Search

Your search keyword '"Ellis, Paul"' showing total 1,423 results

Search Constraints

Start Over You searched for: Author "Ellis, Paul" Remove constraint Author: "Ellis, Paul"
1,423 results on '"Ellis, Paul"'

Search Results

1. The Penults of Tak: Adventures in impartial, normal-play, positional games

2. Categories of impartial rulegraphs and gamegraphs

3. Two Games on Arithmetic Functions: SALIQUANT and NONTOTIENT

4. Tukey morphisms between finite relations

6. The Arithmetic-Periodicity of \textsc{cut} for $\mathcal{C}=\{1,2c\}$

7. ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies

8. Strategies to delay progression of alpha-1 antitrypsin deficiency related lung disease

9. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial

11. Reducing the dichromatic number via cycle reversions in infinite digraphs

12. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

13. The What, Why and How of Assessment: A Guide for Teachers and School Leaders

14. Conjugacy for homogeneous ordered graphs

16. The Classification Problem for Simple Unital Finite Rank Dimension Groups

17. Cycle reversions and dichromatic number in tournaments

21. The conjugacy problem for automorphism groups of homogeneous digraphs

26. The conjugacy problem for the automorphism group of the random graph

27. Cluster randomised controlled trial of specialist-led integrated COPD care (INTEGR COPD).

29. Data from ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies

30. Figure S.1 from ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies

32. Isospin Asymmetry in Nuclei, Neutron Stars, and Heavy-Ion Collisions

33. Isospin Asymmetry in Nuclei and Neutron Stars

34. Impact of CFL Quark Matter on the Cooling of Compact Stars

36. Optically opaque color-flavor locked phase inside compact stars

37. Low Energy Pion--Nucleon Scattering in the Heavy Baryon and Infrared Schemes

38. Thermal conductivity of dense quark matter and cooling of stars

40. Dynamical Evolution of the Scalar Condensate in Heavy Ion Collisions

41. ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies

42. Data from Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade

43. Supplementary Table 3 from PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow

44. Supplementary Figures from Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade

45. Supplementary Table 4 from PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow

46. Supplementary Figure 2 from PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow

47. Supplementary Figure 1 from PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow

48. Supplementary Table 2 from PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow

49. Data from PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow

50. Supplementary Data from Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade

Catalog

Books, media, physical & digital resources